Health Decisions has extensive experience with infectious disease clinical trials, including studies of therapeutic agents, prophylactics and diagnostics. Studies involve a variety of indications, including MRSA, hepatitis C, Clostridium difficile and HIV. Health Decisions’ global capabilities include rapidly adapting enrollment strategy based on prevalence and seasonality of infectious diseases in different regions.
Experience in Infectious Disease Clinical Trials
Experience of Health Decisions’ clinical directors, project managers and CRAs with infectious disease clinical trials covers all phases and a variety of indications, including:
- Chlamydia and gonorrhea
- Clostridium difficile
- Hepatitis C
- Respiratory viruses
- Skin and soft tissue Infection
Download a fact sheet summarizing Health Decisions’ capabilities in infectious disease studies.
View Fact Sheet